- Home
- / CollPlant
CollPlant
Stock Price
$3.9
2024-10-29
Market Capitalization
$44.9 M
2024-10-29
Revenue
$2.4 M
FY, 2025
CollPlant Summary
Company Summary
- Overview
- CollPlant Biotechnologies is a medicine company that specializes in tissue regeneration and organ manufacturing. Its products include dermal fillers; breast implants; Collink.3D Bioinks; Vergenix FG, an advanced wound-care device; Vergenix STR, a soft tissue repair matrix mixed with PRP, etc. The company also specializes in rhCollagen and 3D bioprinting technologies.
- Type
- Public
- Status
- Active
- Founded
- 1981
- HQ
- Rehovot, IL | view all locations
- Website
- https://www.collplant.com
- Cybersecurity rating
Table of Contents
Key People
Abraham Havron, Director
Oded Shoseyov, Founder and Chief Scientist
Hugh Evans, Director
LocationsView all
1 location detected
Rehovot, Tel Aviv District HQ
Israel
4 Oppenheimer Street
CollPlant Financials
Summary Financials
- Revenue (FY, 2025)
- $2.4M
- Gross profit (FY, 2025)
- $1.5M
- Net income (FY, 2025)
- ($11.5M)
- Cash (FY, 2025)
- $5.6M
- EBIT (FY, 2025)
- ($11.5M)